Mohammad A. Al-Ani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mohammad A. Al-Ani has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Alex M. Parker
Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida, USA
2 shared publicationsJuan R. Vilaro
Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida, USA
2 shared publicationsMamoun T. Mardini
Department of Health Outcomes and Biomedical Informatics, University of Florida, Gainesville, Florida, USA
2 shared publicationsMustafa M. Ahmed
Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida, USA
2 shared publicationsAmal Hashky
Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, United States
1 shared publicationAzra Bihorac
Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, United States
1 shared publication
Latest Publications
- Open Access
- 10 June 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 42 (11) , 1597-1607
Utilization of the percutaneous left ventricular support as bridge to heart transplantation across the United States: In-depth UNOS database analysis
- 10 June 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 42 (11) , 1597-1607
Open AccessUtilization of the percutaneous left ventricular support as bridge to heart transplantation across the United States: In-depth UNOS database analysis
- Open Access
- 24 February 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1127716
Artificial intelligence guidance of advanced heart failure therapies: A systematic scoping review
Introduction: Artificial intelligence can recognize complex patterns in large datasets. It is a promising technology to advance heart failure practice, as many decisions rely on expert opinions in the absence of high-quality data-driven evidence.Methods: We searched Embase, Web of Science, and PubMed databases for articles containing “artificial intelligence,” “machine learning,” or “deep learning” and any of the phrases “heart transplantation,” “ventricular assist device,” or “cardiogenic shock” from inception until August 2022. We only included original research addressing post heart transplantation (HTx) or mechanical circulatory support (MCS) clinical care. Review and data extraction were performed in accordance with PRISMA-Scr guidelines.Results: Of 584 unique publications detected, 31 met the inclusion criteria. The majority focused on outcome prediction post HTx (n = 13) and post durable MCS (n = 7), as well as post HTx and MCS management (n = 7, n = 3, respectively). One study addressed temporary mechanical circulatory support. Most studies advocated for rapid integration of AI into clinical practice, acknowledging potential improvements in management guidance and reliability of outcomes prediction. There was a notable paucity of external data validation and integration of multiple data modalities.Conclusion: Our review showed mounting innovation in AI application in management of MCS and HTx, with the largest evidence showing improved mortality outcome prediction.
- 24 February 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1127716
Open AccessArtificial intelligence guidance of advanced heart failure therapies: A systematic scoping review
Introduction: Artificial intelligence can recognize complex patterns in large datasets. It is a promising technology to advance heart failure practice, as many decisions rely on expert opinions in the absence of high-quality data-driven evidence.Methods: We searched Embase, Web of Science, and PubMed databases for articles containing “artificial intelligence,” “machine learning,” or “deep learning” and any of the phrases “heart transplantation,” “ventricular assist device,” or “cardiogenic shock” from inception until August 2022. We only included original research addressing post heart transplantation (HTx) or mechanical circulatory support (MCS) clinical care. Review and data extraction were performed in accordance with PRISMA-Scr guidelines.Results: Of 584 unique publications detected, 31 met the inclusion criteria. The majority focused on outcome prediction post HTx (n = 13) and post durable MCS (n = 7), as well as post HTx and MCS management (n = 7, n = 3, respectively). One study addressed temporary mechanical circulatory support. Most studies advocated for rapid integration of AI into clinical practice, acknowledging potential improvements in management guidance and reliability of outcomes prediction. There was a notable paucity of external data validation and integration of multiple data modalities.Conclusion: Our review showed mounting innovation in AI application in management of MCS and HTx, with the largest evidence showing improved mortality outcome prediction.